NCT03479372 - Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

May 27, 2019

Study Completion Date

June 27, 2019

Conditions

Neovascular Age-related Macular Degeneration

Interventions

DRUG

PAN-90806 Ophthalmic Suspension

PAN-90806 provided in single-use dropper bottles for topical ocular administration

Trial Locations (18)

1085

Semmelweis University, Budapest

4032

University of Debrecen, Debrecen

21740

Cumberland Valley Retina Consultants, Hagerstown

27710

Duke University, Durham

80401

Colorado Retina Associates, Golden

87109

Vision Research Center, Albuquerque

89052

Retinal Consultants of Nevada, Henderson

89144

Retinal Consultants of Nevada, Las Vegas

07003

Retina Center of New Jersey, Bloomfield

07666

Retina Center of New Jersey, Teaneck

100 34

Fakultní nemocnice Královské Vinohrady, Prague

150 00

Axon Clinical, Prague

LV1002

P. Stradina Clinical University hospital, Riga

EN5 3DJ

Barnet Hospital, Barnet

WV10 0QP

New Cross Hospital, Wolverhampton

BD9 6RJ

Bradford Royal Infirmary, Bradford

EC1V 2PD

Moorefields Eye Hospital, London

M13 9WL

Manchester Royal Eye Hospital, Manchester